Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Coloplast A/S Sponsored ADR (CLPBY) had Revenue of $4.13B for the most recently reported fiscal year, ending 2025-09-30.

Quarterly Annual

Figures for fiscal year ending 2025-09-30

Income Statement Financials
Revenue	$4.13B
Net Income	$538.49M
Cost of Goods Sold	$1.32B
Gross Profit	$2.81B
Operating Expenses	$3.06B
Operating Income	$1.07B
Non-Operating Income/Expense	$-154.62M
Pre-Tax Income	$911.85M
Normalized Pre-Tax Income	$911.85M
Income after Taxes	$538.49M
Income from Continuous Operations	$538.49M
Consolidated Net Income/Loss	$538.49M
Normalized Income after Taxes	$538.49M
EBIT	$1.07B
EBITDA	$1.28B
Weighted-Average Shares Outstanding (Basic)	2.25B
Weighted-Average Shares Outstanding (Diluted)	2.25B
Earnings per Share (EPS) (Basic)	$0.24
Earnings per Share (EPS) (Diluted)	$0.24
Balance Sheet Financials
Current Assets	$1.55B
Property, Plant, and Equipment	$918.37M
Long-Term Assets	$5.62B
Total Assets	$7.16B
Current Liabilities	$963.39M
Long-Term Debt	$2.87B
Long-Term Liabilities	$3.81B
Total Liabilities	$4.78B
Common Equity	$2.39B
Tangible Shareholders Equity	$-2.07B
Shareholders Equity	$2.39B
Common Shares Outstanding	2.28B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$984.12M
Cash Flow from Investing Activities	$-185.27M
Cash Flow from Financial Activities	$-768.19M
Beginning Cash	$116.70M
End Cash	$140.25M
Increase/Decrease in Cash	$23.55M
Stock-Based Compensation	--
Common Stock Dividends Paid	$-734.28M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.61
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.55
Debt to Equity Ratio	1.20
Gross Margin	67.97%
Operating Margin	25.83%
EBIT Margin	25.83%
EBITDA Margin	31.05%
Pre-Tax Profit Margin	22.09%
Profit Margin	13.04%
Free Cash Flow	$791.45M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.58
Inventory Turnover	2.28
Receiveable Turnover	5.39
Days Sales in Receivables	67.78
Return on Equity	22.55%
Return on Tangible Equity	-25.96%
Return on Assets	7.52%
Return on Investments	10.25%
Book Value Per Share	$1.05
Free Cash Flow per Share	$0.35
Operating Cash Flow per Share	$0.44

Data from Zacks Investment Research, Inc.